Metrics Inc. has appointed Joe Cascone as senior director of operations. In his new role at...
Metrics Inc. has named Dr. Thomas B. “Brad” Gold vice president of pharmaceutical development.
AAIPharma Services Corp., a provider of pharmaceutical product development services, announced...
Tau Therapeutics LLC announced two key hires for its executive management team. Bruce A. Silver, MD, FACP, as Chief Medical Officer will lead Tau’s clinical development and research program centered on mibefradil and its novel Interlaced Therapy™ approach. Paul H. Sartori, PhD, MBA, will fill the new position of Vice President of Operations and Strategy.
Bristol-Myers Squibb Appoints Mike Burgess M.D., Ph.D. Senior Vice President, Discovery Medicine and Clinical PharmacologyJanuary 18, 2013 2:56 am | News | Comments
Bristol-Myers Squibb Company announced that Mike Burgess M.D., Ph.D. has joined the Company as senior vice president, Discovery Medicine and Clinical Pharmacology.
Norwich Pharmaceuticals has announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development and technical services (PDTS).
The new, expanded membership of AstraZeneca’s Senior Executive Team, which comes into effect immediately, includes increased representation of the company’s scientific expertise, key products and key markets.
AMRI has announced that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately.
Patheon Inc., a provider of contract development and manufacturing services to the global pharmaceutical industry, today announced, in connection with the close of the Banner acquisition, that Geoff Glass has been appointed president of the new proprietary products business unit.
AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.
BEDMINSTER, N.J. (AP) — Amarin Corp. PLC says it has secured new financing and will hire sales staff to get its fish-oil drug to market.
AmerisourceBergen Names Peyton R. Howell as Senior Vice President, AmerisourceBergen Corporation and President, Global Sourcing and Manufacturer RelationshipsDecember 5, 2012 2:53 am | News | Comments
AmerisourceBergen Corporation today announced that Peyton R. Howell has been named Senior Vice President, AmerisourceBergen Corporation and President, Global Sourcing and Manufacturer Relations, effective immediately.
AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has appointed David Browne as the company's director of analytical chemistry for its Edison, N.J. laboratory.
LOS ANGELES (AP) — ImmunoCellular Therapeutics Ltd. on Monday named Andrew Gengos as president and CEO.
Mark Ricketts has been promoted to Vice President, Alcohol Products at Grain Processing Corporation.
Valeant Pharmaceuticals International, Inc. announced today that Ryan Weldon and Jason Hanson will be named to Valeant's Executive Management Team.
Dr. Reddy’s Laboratories Ltd. today announced that Umang Vohra, who was the CFO of the company for the past four years, will take over the role of Executive Vice-President and Head of North America Generics Business from January 2013.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the appointment of Victor Knopov, Ph.D. to its executive management team as Vice President, Pharmaceutical Development
Walgreen CEO Gregory D. Wasson's total compensation slipped in fiscal 2012, as earnings sank 21 percent and a contract dispute hurt revenue for the nation's largest drugstore operator.
ROCKVILLE, Md. (AP) — Emergent BioSolutions Inc. said Monday that it has appointed Robert Kramer as its new chief financial officer.
Teva Pharmaceutical Industries Ltd. has announced management changes to its executive leadership team.
Cedarburg Hauser Pharmaceuticals, a contract development and manufacturing organization (CDMO), has announced the appointment of John K. Lynch, Ph.D. as its Chief Scientific Officer (CSO).
Watson Pharmaceuticals, Inc. has announced the Global Generics management team, following the announcement of the completion of the acquisition of the Actavis Group .
AMRI Promotes Steven R. Hagen, Ph.D., to Senior Vice President of Pharmaceutical Development and ManufacturingOctober 22, 2012 4:14 am | News | Comments
AMRI announced today that Steven R. Hagen, Ph.D., has been promoted to senior vice president of pharmaceutical development and manufacturing.
Bristol-Myers Squibb Company has announced that Frances Heller has joined the company as senior vice president, Business Development,. She will report to Lamberto Andreotti, chief executive officer, and will be a member of the company’s Senior Management Team.
McKesson Corporation today announced that Mark Walchirk has been named president, McKesson U.S. Pharmaceutical, effective immediately.
Elan Corporation, plc has announced the appointment of Hans Peter Hasler as Chief Operating Officer (“COO”) of the company with effect from October 1, 2012.
- Page 1